to do the kinds of things that I thought were important, that the researchers who NICHD thought were important. There were constraints, of course, on confidentiality and respect. For example, once I asked our then director, Duane Alexander, whether I could issue a funding opportunity. Announcement calling for research on abortion, and he said, "Get real, Susan." But one of the stated missions of NICHD, an institute started by JFK's sister, Ethel, is to assure that all children are born healthy and WANTED.
Where was I in the bureaucracy? The Department of Health and Human Services has 80,000 employees and 11 divisions, including NIH. NIH is one of the largest divisions, about 20,000 employees, in 26 different institutes and centers. The NIH Director is appointed by the President, as is the Director of the National Cancer Institute. All the other institute directors are appointed by the Director of the NIH, so they do not require congressional approval. The Director, since 2009, has been Francis Collins, a geneticist. NICHD is one of the middle-sized institutes with 15 sections and about 1700 employees. The Director, since 2016, is Diana Bianchi, a geneticist, as are the directors of several other institutes. Is there a pattern here?
Within the NICHD, as with all institutes, there is an intramural research division, like a university without students, with departments and faculty and research conducted in house. The other component, the NICHD Division of Extramural Research manages 13 sections with about 800 employees. This paper is a worm's eye view of what I saw then and what I think about it. I started at NICHD in October of 1988, when HIV was still grim, although it had been recognized as a disease since 1981 and there have been some people, including the 2018 SBSRN awardee, Tom Coates, who have been working in the field of HIV prevention for a long, long time. In 1988, I had come from PPFA, where I had just organized a 2-day seminar on sexual behavior research, was not something that Planned Parenthood was comfortable with. Family planning, yes, but family planning was "exposure to the risk of a fertility event" not sex. However, before I got my PhD I worked at the YWCA on the Iowa State campus in Ames, Iowa, where I helped run the Sexual Attitude Reassessments there. Does anybody remember SARS? They were started at the University of Minnesota, presented as weekend workshops on sexual behavior, sexuality, thinking about reassessing one's own behaviors about sex. Mary Briggs, who was one of the SAR trainers came to talk to us and said, "One of the reasons that Americans are so weird about sex may be because we get this double message. 'Sex is fantastic, sex is wonderful. Do not talk about it. And sex is nasty and dirty and disgusting and you save it for somebody you love'-No wonder people are crazy." How much has changed? Sex sells commodities, but other than that, do not talk about it.
As HIV got more and more attention, media attention, and more and more people were found to be infected, studying sexual behavior became somewhat more respectable. National Institute of Allergy and Infectious Diseases and National Cancer Institute were funding most of the biomedical research. NICHD was still thinking about contraception, and not about nonprocreative sex. At that point, my branch and some other people, mostly psychologists from National Institutes of Mental Health, were holding what was known as "AIDS lunch." Once a week they would get together and talk about AIDS-related social and behavioral research issues. Office of AIDS Research was initiated around that time, which focused more research funding on all aspects of the disease. This led, in part, to the NIH AIDS budget allocation growing from less than 1% in maybe 1987 until about 10%. Now it is beginning to get smaller. Even as the whole NIH budget doesn't change, the proportion that's going into HIV/AIDS research is dropping. And of that, only about 4% or 5% of the funding goes into social and behavioral science research. It is important to be persistent in making sure that attention is paid to the behavioral aspects of this disease, (and others, as well), and to evaluate programs and policies designed to prevent its spread. I suspect that zip code may be as important, or even MORE important a factor in disease spread as is genetic code.
At the NIH who decides on funding priorities? I am sure that everybody will have their own tale on this, but in effect it beats me. Peer review evaluates the scientific soundness of applications submitted. Then, each institute has a standing advisory committee that meets 3 times a year, and a range of other advisory committees which also meet in various and sundry ways. The one I will tell you a little bit about because itis one I was intimately involved with, was set up in 2014 to redesign the contraceptive program at NICHD. It met several times, had a perhaps 30 biomedical people and 2 or 3 social scientists. The group wrote a report that in the end was-well, we staff people were told that it was too sensitive for us to see it. We were supposed to respond to it, but we couldn't see it. As a result it seems that this one was focused on "should the NIH develop male contraceptives or female contraceptives?," not "should the NIH look at more about why people do not use the contraceptives that are available?" I continue to be struck by the parallels between ART "failure" and contraceptive "failure." In my opinion, by and large, it is not the ART or the contraceptive that fails, it is human failure. If you do not put a condom on, it does not work, but if you say you are using condoms and you have not used one and you get a disease or your girlfriend gets pregnant. Let us be real. This is a human failure.
But back to funding. The dynamic of funding during regular funding cycles is theoretically transparent, with the advisory councils giving their recommendations to the Director based on the recommendations of the peer review committees and the staff, but there can be wiggle room. This is a place where pressure needs to be applied, steady, consistent pressure. Keep reminding the biomedical folks that understanding human behaviors is essential. Consider the British epidemiologist, John Snow, who stopped a cholera epidemic by taking the handle of a community pump. For social and behavioral scientists, is essential to keep up the pressure, and the flow of research applications. We are hearing that the flow of applications is decreasing. This does NOT result in better scores for those who do apply. It does mean that when the flow of applications slows down, a study section may be shut down, which means that your options for expert peer review sink. So keep the applications coming. Suffering will make you beautiful. Also keep publishing, not only in the academic journals, but in the regular press. An article in the New York Times may be able to do more for social science support and human health than an article in an obscure journal. Think about the popular press, think about talking to the people from Vanity Fair or from Time magazine, from The Economist.
The tension at NIH between funding biomedical research and funding social and behavioral science research, is in part the tension between prevention and cure. Prevention is public health and cure is basic science, so sometimes that is a challenge. Rather than just putting all the money into PrEP or all the money into a vaccine, it is important to maintain a range of options. There is no "one size-fits-all." Not for any health issue, be it to decrease impaired driving, to cut smoking rates, to decrease unwanted pregnancies, or to cut the opioid epidemic. We need to keep pointing out that even the medical answers like the vaccine for HPV is underused. There are almost always behavioral or social structural issues. Think zip code, not genetic code.
What is my advice now that I am no longer an insider? My colleague Willo Pequegnat, also retired, has referred to those of us who have been working in the field since the 80 seconds, as "fossils." But I am here to tell you that fossil records can provide a lot of advice about future directions. My advice is
• Do not self-censor. For instance, I heard a very well-funded person in the family planning field, saying, "The NIH is no longer funding contraceptive research." It was news to me. It was news to the people in my branch. When you hear a rumor like that, check it out, check it out with people who are making decisions about funding, because by and large, it is not true. Fake news is not just something that that man in the White House talks about. And also, if you believe your research is far too sensitive to be funded by the NIH and you do not send it in, you are not going to get funded. Maybe a foundation will come upon you and say, "Go forth and do the work," or maybe you will win the lottery. But the NIH sure as hell is not going to fund you if you do not apply. • Follow the directions in the call for research. This is not the place to be innovative. Follow the directions. Your design can and should be innovative, but remember that reviewers are reading 8 or 10 applications and appreciate being able to expect that sections of an application will follow a standard design. • Remember that peer review is not perfect. But over time and space it is better than the next best thing. It does not rely on the opinion of one expert in the field, it is a committee. Peer review at the NIH is a long and bureaucratic process, but in effect, it is the bureaucracy at NIH who is protecting us all from the behaviors of the people in that adult daycare center at 1600 Pennsylvania Avenue. It is the bureaucratic process that protects us, so protect our bureaucrats, please. Volunteer to be on study sections when asked. • Remember, NIH is a biomedical organization and we social and behavioral scientists are tolerated. We have to keep reminding them that John Snow did stop cholera. He removed the handle from a pump. He did not inject people with a vaccine. He removed the handle from the pump. That is a behavioral intervention. Behavior is critical and key. • Remember the Edmund Burke quote "All that is necessary for evil to triumph is for good men to do nothing." You can bitch about saying "men" rather than "good people" but do not forget the facts. Or, if you are a fossil, go to Pogo, who said, "We have met the enemy and he is us,"
Then if your application is selected for funding, listen up. You can go on and on about purity and pragmatics because the NIH may ask you to change some words in the title or abstract, but in my 29 years at NICHD only one grant has been defunded after it was funded, and that was a result of NC Senator Jesse Helms' pressure about Dick Udry's adolescent sexual behavior study. Udry revised it, retitled it, and resubmitted it. It got a perfect score in 1993. It is in its fourth round of a program project now. And lo and behold, the science showed that teenagers were not screwing like bunnies which finding led the original opponents of the research to claim it as their own. back off. That award used to be managed by NICHD, but the next round is going to NIA. The subjects, who were teenagers in the 1990s, are now getting into their middle age. And National Institutes of Mental Health, as many are aware, is not exclusively funding the lack of mental health. Loyalty to one institute or insistence on purity may not serve your research agenda.
Here is another wonderful self-censorship story. This was a Small Business Technology Transfer grant entitled: "Improving the Fit of HIV Prevention." The team goal was to convince the Federal Drug Administration (FDA) to permit a wide range of sizes of condoms to be sold in the United States. The FDA said, "No, no. American men cannot measure their penis size. Therefore, we're not going to permit you to do that." The team convinced the FDA to permit more than 2 sizes to be sold. Now, within the next year or so you are going to see 60 sizes of condoms available by mail order in the United States. So think about Scientific Technology Transfer Researchs. If you have got a colleague who has a small, for-profit business and you have got an idea, the collaboration between academics and for-profit organizations, the SBIRs and Scientific Technology Transfer Researchs have a much better pay line. Think about that approach. It is entrepreneurial, that is to say, trendy.
One final observation, about your relationship with the NIH. Mostly, you will be dealing with a program officer in a branch. Remember that they are all human beings and are as diverse as the population of researchers whose work they monitor. Furthermore, being a Fed adds another layer of bureaucracy and more people to look over their shoulders and second guess them. As the money gets less and the need gets greater, the tension in program people increases. In addition, the tension is getting worse at the NIH and at other places about what CAN be said. This results in more concern about "they may be watching; they may be listening; I have got to be careful of what I say." Personal dynamics exist, even at the NIH, so cut those program officers some slack because they are human beings and they have got other tensions that maybe they cannot talk about with you. Ask, but be prepared for unsatisfactory answers. In science as in life. But keep up the pressure, good luck.
